New cancer therapy treatment emerges in Manitoba
At a press conference on Monday, the Minister of Health, Audrey Gordon, was delighted that patients could soon be treated closer to home.
Patients who respond poorly conventional treatments for certain forms of blood cancers will have access to a new specialized program in Manitoba, provincial Health Minister Audrey Gordon announced Monday.
The province is investing $6.6 million in a chimeric antigen receptor (CAR-T) cancer therapy program, in partnership with CancerCare Manitoba, the minister said at a press conference.
This is a relatively new area of life-saving cancer therapy, and we are pleased to help CancerAction to x27; offer in Manitoba, she says.
The province explains in a statement that the Chimeric Antigen Receptor-Based Cancer Therapy (CAR-T) program offers personalized immunotherapy for people with blood cancer or lymphatic cancer. , such as lymphoma, and do not respond well to conventional treatments.
This therapy, which will be implemented next spring, will initially be offered to people aged 25 or younger with acute leukemia, including children, as well as adults aged 18 and over with acute leukemia. catastrophic lymphoma, if other therapies have not worked.
This treatment represents the future of this field, according to doctors and scientists present at this announcement.< /p>
CancerCare Manitoba President and CEO, Dr. Sri Navaratnam, is pleased to introduce Manitobans to a project that will deliver high-quality treatments based on evidence.
She clarified that the clinical team is ready, but that there are logistical checks to be done before kicking off the program.
We will now be able to to provide life-saving CAR-T therapy to patients closer to home, closer to their family and support system, which is very important to their recovery and a priority for CancerCare Manitoba, says Dr. Navaratnam.
Up to eight patients a year could benefit from this treatment. This number could increase in the coming years, as Dr. Navaratnam points out.
Audrey Gordon points out that this approach will attract and retain highly qualified technicians and researchers. working in this area of cancer therapy.
Manitoba presently sends several patients each year for CAR-T therapy in residential care healthcare located outside the province.